Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Differential gene expression in non-malignant tumour microenvironment is associated with outcome in follicular lymphoma patients treated with rituximab and CHOP.
Br J Haematol. 2006 Oct;135(1):33-42. doi: 10.1111/j.1365-2141.2006.06255.x. Epub 2006 Aug 22.
Br J Haematol. 2006.
PMID: 16925574
Free article.
Rituximab (anti-CD20) therapy of B-cell lymphomas: direct complement killing is superior to cellular effector mechanisms.
Harjunpää A, Junnikkala S, Meri S.
Harjunpää A, et al.
Scand J Immunol. 2000 Jun;51(6):634-41. doi: 10.1046/j.1365-3083.2000.00745.x.
Scand J Immunol. 2000.
PMID: 10849376
Free article.
Item in Clipboard
Complement activation in circulation and central nervous system after rituximab (anti-CD20) treatment of B-cell lymphoma.
Harjunpää A, Wiklund T, Collan J, Janes R, Rosenberg J, Lee D, Grillo-López A, Meri S.
Harjunpää A, et al.
Leuk Lymphoma. 2001 Aug;42(4):731-8. doi: 10.3109/10428190109099335.
Leuk Lymphoma. 2001.
PMID: 11697503
Item in Clipboard
Increased incidence of Mycoplasma pneumoniae infection in Finland, 2010-2011.
Polkowska A, Harjunpää A, Toikkanen S, Lappalainen M, Vuento R, Vuorinen T, Kauppinen J, Flinck H, Lyytikäinen O.
Polkowska A, et al. Among authors: harjunpaa a.
Euro Surveill. 2012 Feb 2;17(5):20072. doi: 10.2807/ese.17.05.20072-en.
Euro Surveill. 2012.
PMID: 22321135
Free article.
Item in Clipboard
Cite
Cite